Global Thyroid Cancer Diagnostics Market Report 2024

Thyroid Cancer Diagnostics Global Market Report 2024 – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Type), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End-User (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Thyroid Cancer Diagnostics Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Thyroid Cancer Diagnostics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Thyroid Cancer Diagnostics Market Definition And Segments

Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for thyroid cancer present in the body and helps in diagnosing thyroid cancer. Thyroid cancer refers to a type of cancer that starts in the thyroid gland when cells begin to grow out of control.

The main techniques in thyroid cancer diagnostics are imaging tests, blood tests, biopsies, and others. Imaging refers to the process of creating images that depict phenomena such as temperature, sound waves, chemicals, or electrical activity. Imaging tests are used in thyroid cancer diagnostics to produce images of the thyroid gland. The various disease types include papillary carcinoma, follicular carcinoma, and others. These are used by various end-users such as hospital laboratories, cancer diagnostic centers, research institutes, and others.

The thyroid cancer diagnostics market covered in this report is segmented –

1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type

2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases

3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users

The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.79 billion in 2023 to $2.97 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives and funding, improved healthcare infrastructure.

The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships.

The Surge In Thyroid Cancer Prevalence And Its Implications On The Diagnostic Market

The increasing prevalence of thyroid cancer is driving the growth of the thyroid cancer diagnostic market going forward. Thyroid cancer is a disease in the thyroid gland (a gland near the base of the throat that produces hormones to help regulate body temperature, heart rate, blood pressure, and weight). Thyroid cancer diagnostics help to discover thyroid cancer by providing early detection that can help improve treatment outcomes. Thus, the increasing prevalence of thyroid cancer increases the demand for the diagnostic market. For instance, in September 2023, according to a report published by the American Cancer Society, a US-based non-profit organization, there are anticipated to be approximately 43,720 new cases of thyroid cancer, with 12,540 occurring in men and 31,180 in women in 2023. The projected number of deaths from thyroid cancer in the same year is around 2,120, with 970 in men and 1,150 in women. Therefore, thyroid cancer's increasing prevalence is propelling the diagnostic market of thyroid cancer.

The Impact Of Escalating Healthcare Spending On The Precision Diagnostics Market

The increased healthcare spending is expected to boost the growth of the thyroid cancer diagnostics market going forward. Healthcare spending refers to the total monetary resources allocated to the provision of healthcare goods and services within a specific region or country over a defined period. Increased healthcare spending fuels the thyroid cancer diagnostics market by channeling more resources into the research, development, and implementation of advanced diagnostic technologies, enhancing accessibility and affordability of innovative tools for early detection and improved management of thyroid cancer. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that, on average, national health spending is expected to increase by 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the increased healthcare spending is driving the growth of the thyroid cancer diagnostics market.

Major companies operating in the thyroid cancer diagnostics market report are Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline PLC, Canon Inc., Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, AstraZeneca PLC, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.

Product Innovations In The Thyroid Cancer Diagnostic Market

Major companies operating in the thyroid cancer diagnostic market are developing innovative products such as oral tablets to meet larger customer bases, more sales, and increase revenue. Oral tablets are solid pharmaceutical dosage forms designed for oral administration. For instance, in September 2021, Exelixis Inc., a US-based biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval for CABOMETYX (cabozantinib). It is indicated for treating differentiated thyroid cancer (DTC) in adults and pediatric patients aged 12 and above who have locally advanced or metastatic disease. This treatment is specifically for cases that have advanced after previous vascular endothelial growth factor receptor (VEGFR)-targeted therapy and where patients are either refractory to radioactive iodine or ineligible for such treatment. CABOMETYX tablets have received approval for multiple indications, including the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma in patients previously treated with sorafenib, first-line treatment for advanced RCC in combination with nivolumab, and the management of locally advanced or metastatic differentiated thyroid cancer (DTC) in adult and pediatric patients aged 12 and older.

Product Innovations In The Thyroid Cancer Diagnostic Market

Major companies operating in the thyroid cancer diagnostic market are developing innovative products such as rearranged during transfection (RET) inhibitors, to meet larger customer bases, more sales, and increase revenue. A RET inhibitor is a type of drug or compound that specifically targets and inhibits the activity of the RET (rearranged during transfection) protein. For instance, in March 2022, CStone Pharmaceuticals, a China-based biopharma company, announced the National Medical Products Administration (NMPA) of China approval for GAVRETO (pralsetinib). GAVRETO stands out as the unique and exclusive selective rearranged during transfection (RET) inhibitor sanctioned in China for managing RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC). This once-daily oral targeted therapy, approved by the National Medical Products Administration (NMPA) of China, exhibits its distinctive quality by being the sole option for treating adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer (NSCLC) after platinum-based chemotherapy. Furthermore, GAVRETO is approved for the treatment of adult and pediatric patients aged 12 years and older with advanced or metastatic RET-mutant MTC requiring systemic therapy. It also addresses the needs of adult and pediatric patients aged 12 years and older with advanced or metastatic RET fusion-positive TC who require systemic therapy and are radioactive iodine-refractory, if radioactive iodine treatment is deemed appropriate.

Veracyte Inc. Acquired Haliodx

In August 2021, Veracyte Inc., a US-based diagnostics provider, acquired HalioDx for $279 million. This acquisition helps Veracyte Inc. bring innovative, best-in-class diagnostic products to market and fuels its growth in cancer diagnostics. HalioDx is a France-based diagnostic company that provides oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services.

North America was the largest region in the thyroid cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer diagnostics market statistics, including thyroid cancer diagnostics industry global market size, regional shares, competitors with a thyroid cancer diagnostics market share, detailed thyroid cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. This thyroid cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thyroid Cancer Diagnostics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.97 billion
Revenue Forecast In 2033 $3.7 billion
Growth Rate CAGR of 5.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; General Electric; F. Hoffmann-La Roche AG; Bayer AG; Novartis International AG; Sanofi S.A.; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Abbott Laboratories; GlaxoSmithKline plc; Canon Inc.; Eli Lilly and Company; Toshiba Corporation; Merck KGaA; Siemens Healthcare GmbH; FUJIFILM Holdings Corporation; Koninklijke Philips N.V.; GE Healthcare; AstraZeneca plc; Agilent Technologies Inc.; Hologic Inc.; Genzyme Corporation; Illumina Inc.; BioMérieux SA; Bio-Rad Laboratories Inc.; Quest Diagnostics Inc.; Qiagen N.V.; Cepheid; Veracyte Inc.; DiaSorin S.p.A.; Myriad Genetics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Thyroid Cancer Diagnostics Market Characteristics

    3. Thyroid Cancer Diagnostics Market Trends And Strategies

    4. Thyroid Cancer Diagnostics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Thyroid Cancer Diagnostics Market Size and Growth

    5.1. Global Thyroid Cancer Diagnostics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Thyroid Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Thyroid Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Thyroid Cancer Diagnostics Market Segmentation

    6.1. Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Imaging Test

    Blood Test

    Biopsy

    Other Test Type

    6.2. Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Papillary Carcinoma

    Follicular Carcinoma

    Other Diseases

    6.3. Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Laboratories

    Cancer Diagnostic Centers

    Research Institutes

    Other End-Users

    7. Thyroid Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Thyroid Cancer Diagnostics Market

    8.1. Asia-Pacific Thyroid Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Thyroid Cancer Diagnostics Market

    9.1. China Thyroid Cancer Diagnostics Market Overview

    9.2. China Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Thyroid Cancer Diagnostics Market

    10.1. India Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Thyroid Cancer Diagnostics Market

    11.1. Japan Thyroid Cancer Diagnostics Market Overview

    11.2. Japan Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Thyroid Cancer Diagnostics Market

    12.1. Australia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Thyroid Cancer Diagnostics Market

    13.1. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Thyroid Cancer Diagnostics Market

    14.1. South Korea Thyroid Cancer Diagnostics Market Overview

    14.2. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Thyroid Cancer Diagnostics Market

    15.1. Western Europe Thyroid Cancer Diagnostics Market Overview

    15.2. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Thyroid Cancer Diagnostics Market

    16.1. UK Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Thyroid Cancer Diagnostics Market

    17.1. Germany Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Thyroid Cancer Diagnostics Market

    18.5. France Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Thyroid Cancer Diagnostics Market

    19.9. Italy Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Thyroid Cancer Diagnostics Market

    20.13. Spain Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Thyroid Cancer Diagnostics Market

    21.1. Eastern Europe Thyroid Cancer Diagnostics Market Overview

    21.2. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Thyroid Cancer Diagnostics Market

    22.1. Russia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Thyroid Cancer Diagnostics Market

    23.1. North America Thyroid Cancer Diagnostics Market Overview

    23.2. North America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Thyroid Cancer Diagnostics Market

    24.1. USA Thyroid Cancer Diagnostics Market Overview

    24.2. USA Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Thyroid Cancer Diagnostics Market

    25.1. Canada Thyroid Cancer Diagnostics Market Overview

    25.2. Canada Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Thyroid Cancer Diagnostics Market

    26.1. South America Thyroid Cancer Diagnostics Market Overview

    26.2. South America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Thyroid Cancer Diagnostics Market

    27.1. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Thyroid Cancer Diagnostics Market

    28.1. Middle East Thyroid Cancer Diagnostics Market Overview

    28.2. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Thyroid Cancer Diagnostics Market

    29.1. Africa Thyroid Cancer Diagnostics Market Overview

    29.2. Africa Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Thyroid Cancer Diagnostics Market Competitive Landscape And Company Profiles

    30.1. Thyroid Cancer Diagnostics Market Competitive Landscape

    30.2. Thyroid Cancer Diagnostics Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. General Electric

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bayer AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis International AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Thyroid Cancer Diagnostics Market Other Major And Innovative Companies

    31.1. Sanofi S.A.

    31.2. Bristol-Myers Squibb Company

    31.3. Thermo Fisher Scientific Inc.

    31.4. Abbott Laboratories

    31.5. GlaxoSmithKline plc

    31.6. Canon Inc.

    31.7. Eli Lilly and Company

    31.8. Toshiba Corporation

    31.9. Merck KGaA

    31.10. Siemens Healthcare GmbH

    31.11. FUJIFILM Holdings Corporation

    31.12. Koninklijke Philips N.V.

    31.13. GE Healthcare

    31.14. AstraZeneca plc

    31.15. Agilent Technologies Inc.

    32. Global Thyroid Cancer Diagnostics Market Competitive Benchmarking

    33. Global Thyroid Cancer Diagnostics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market

    35. Thyroid Cancer Diagnostics Market Future Outlook and Potential Analysis

    35.1 Thyroid Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Thyroid Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Thyroid Cancer Diagnostics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: General Electric Financial Performance
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Novartis International AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: General Electric Financial Performance
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Novartis International AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Automobile Rental And Leasing Market - By Type (Passenger Car Rental , Passenger Car Leasing, Truck, Utility Trailer, And Recreational Vehicle Rental And Leasing), By Type Of Mode (Offline, Online), By Type Of Lease (Open, Close), By End User (Individual, Corporate), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Automotive Repair and Maintenance Global Market Report 2024 – By Type (Automotive Mechanical And Electrical Repair And Maintenance, Automotive Body, Paint, Interior, And Glass Repair, Other Automotive Repair And Maintenance), By Vehicle Type (Passenger Cars, Light Commercial Vehicles, Heavy Commercial Vehicles, Bike And Scooter), By Service Provider (Automotive Dealership, Franchise General Repair, Specialty Shop, Locally Owned Repair Shops/Body Shop, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Halogen Bulbs Global Market Report 2024 – By Product (Halogen Short-Arc Lights, Halogen Long-Arc Lights, Halogen Flash Lights), By Vehicle Type (Passenger Vehicle, Commercial Vehicle), By Application (OEMs, Aftermarket) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Light Emitting Diode (LED) Bulbs Global Market Report 2024 – By Vehicle Type (Passenger Car, Light Commercial Vehicle (LCV), Heavy Commercial Vehicle (HCV)), By Adaptive Lighting (Front Adaptive Lighting, Rear Adaptive Lighting, Ambient Adaptive Lighting), By Sales Channel (OEM, Aftermarket) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Cables Global Market Report 2024 – By Product Type (Copper Core, Aluminum Core, Other Product Types), By Sales Channel (Direct Channel, Distribution Channel), By Application (Automotive Primary Wire and Battery Cable, Brake Cable, Trailer Cable, Car Speaker Wire, Fusible Link Wire) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Motor Vehicle And Parts Dealers Global Market Report 2024 – By Type (Auto Parts And Accessories, Automobile Dealers, Other Motor Vehicle Dealers), By Ownership (Retail Chain, Independent Retailer), By Type of Store (Exclusive Retailers or Showroom, Inclusive Retailers or Dealer Store) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automobiles And Heavy Equipment Global Market Report 2024 – By Type (Business Services, Managed Services, System Integrator, Other Types), By Size (Heavy Trucks, Medium Trucks, Light Trucks), By Application (Cars And Light Trucks, Medium And Heavy Trucks, Farm And Construction Equipment, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Electric Motor And Generator Global Market Report 2024 – By Type (Electric Motors, Electric Generators), By Application (Industrial Machinery, Automobile (Motor Vehicle), HVAC (Heating, Ventilation, And Air Conditioning), Other Applications), By End User (Industrial, Residential, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the thyroid cancer diagnostics market?

Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for thyroid cancer present in the body and helps in diagnosing thyroid cancer. Thyroid cancer refers to a type of cancer that starts in the thyroid gland when cells begin to grow out of control. For further insights on the thyroid cancer diagnostics market, request a sample here

How will the thyroid cancer diagnostics market drivers and restraints affect the thyroid cancer diagnostics market dynamics? What forces will shape the thyroid cancer diagnostics industry going forward?

The thyroid cancer diagnostics market major growth driver - The Surge In Thyroid Cancer Prevalence And Its Implications On The Diagnostic Market. For further insights on the thyroid cancer diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the thyroid cancer diagnostics market?

The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.79 billion in 2023 to $2.97 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives and funding, improved healthcare infrastructure.. The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances.. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships. For further insights on the thyroid cancer diagnostics market, request a sample here

How is the thyroid cancer diagnostics market segmented?

The thyroid cancer diagnostics market is segmented
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-UsersFor further insights on the thyroid cancer diagnostics market, request a sample here

Which region has the largest share of the thyroid cancer diagnostics market? What are the other regions covered in the report?

North America was the largest region in the thyroid cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the thyroid cancer diagnostics market, request a sample here.

Who are the major players in the thyroid cancer diagnostics market?

Major companies operating in the thyroid cancer diagnostics market report are Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Canon Inc., Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc. For further insights on the thyroid cancer diagnostics market, request a sample here.

What are the key trends in the thyroid cancer diagnostics market?

Major trend in the thyroid cancer diagnostics market - Product Innovations In The Thyroid Cancer Diagnostic Market. For further insights on the thyroid cancer diagnostics market, request a sample here.

What are the major opportunities in the thyroid cancer diagnostics market? What are the strategies for the thyroid cancer diagnostics market?

For detailed insights on the major opportunities and strategies in the thyroid cancer diagnostics market, request a sample here.

How does the thyroid cancer diagnostics market relate to the overall economy and other similar markets?

For detailed insights on thyroid cancer diagnostics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the thyroid cancer diagnostics industry?

For detailed insights on the mergers and acquisitions in the thyroid cancer diagnostics industry, request a sample here.

What are the key dynamics influencing the thyroid cancer diagnostics market growth? SWOT analysis of the thyroid cancer diagnostics market.

For detailed insights on the key dynamics influencing the thyroid cancer diagnostics market growth and SWOT analysis of the thyroid cancer diagnostics industry, request a sample here.